PSN 010
Alternative Names: LY 2599506; PSN010Latest Information Update: 05 Nov 2023
At a glance
- Originator Prosidion
- Developer Eli Lilly and Company
- Class Antihyperglycaemics
- Mechanism of Action Glucokinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Suspended Type 2 diabetes mellitus
Most Recent Events
- 15 Sep 2011 Final adverse events and pharmacodynamics data from a phase I trial in Type-2 diabetes mellitus presented at the 47th Annual meeting of the European Association for the Study of Diabetes (EASD-2011)
- 24 Jun 2010 Suspended - Phase-II for Type-2 diabetes mellitus in Australia (PO)
- 24 Jun 2010 Suspended - Phase-II for Type-2 diabetes mellitus in Europe (PO)